AGT and breast carcinoma: ER− (pII and MDA-MB-231) and ER+ (YS1.2) breast cancer cells were treated with various concentrations (0.1, 1, and 10 μM) of Ang II for 96 h, and cell proliferation was determined using the MTT assay.